PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 103 filers reported holding PASSAGE BIO INC in Q4 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $116,414 | +11.2% | 176,920 | +59.1% | 0.00% | – |
| Q2 2023 | $104,673 | -59.7% | 111,201 | -59.0% | 0.00% | – |
| Q1 2023 | $259,702 | +403.7% | 271,172 | +625.7% | 0.00% | – |
| Q4 2022 | $51,563 | -91.8% | 37,365 | -92.6% | 0.00% | – |
| Q3 2022 | $629,000 | -74.6% | 502,454 | -52.2% | 0.00% | – |
| Q2 2022 | $2,479,000 | +20.5% | 1,050,967 | +58.4% | 0.00% | – |
| Q1 2022 | $2,057,000 | -79.1% | 663,418 | -57.3% | 0.00% | -100.0% |
| Q4 2021 | $9,856,000 | -13.5% | 1,552,104 | +35.7% | 0.00% | -50.0% |
| Q3 2021 | $11,389,000 | -25.0% | 1,143,442 | -0.3% | 0.00% | 0.0% |
| Q2 2021 | $15,177,000 | +43.3% | 1,146,346 | +89.2% | 0.00% | 0.0% |
| Q1 2021 | $10,589,000 | -2.4% | 605,800 | +42.8% | 0.00% | 0.0% |
| Q4 2020 | $10,851,000 | +102.1% | 424,348 | +3.6% | 0.00% | +100.0% |
| Q3 2020 | $5,369,000 | -49.9% | 409,574 | +4.4% | 0.00% | -50.0% |
| Q2 2020 | $10,719,000 | +132.6% | 392,158 | +34.0% | 0.00% | +100.0% |
| Q1 2020 | $4,609,000 | – | 292,652 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $1,648,629 | 2.12% |
| Versant Venture Management, LLC | 4,959,769 | $3,263,528 | 1.74% |
| BML Capital Management, LLC | 2,058,767 | $1,354,669 | 1.24% |
| Acuitas Investments, LLC | 418,161 | $275,150 | 0.16% |
| Orbimed Advisors | 10,124,576 | $6,661,971 | 0.14% |
| Lynx1 Capital Management LP | 190,124 | $125,102 | 0.08% |
| Frazier Life Sciences Management, L.P. | 1,758,219 | $1,156,908 | 0.08% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $263,200 | 0.04% |
| Marquette Asset Management, LLC | 86,050 | $56,621 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 506,600 | $333,343 | 0.01% |